LMAT vs. ZBH
Compare and contrast key facts about LeMaitre Vascular, Inc. (LMAT) and Zimmer Biomet Holdings, Inc. (ZBH).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LMAT or ZBH.
Key characteristics
| LMAT | ZBH | |
|---|---|---|
| YTD Return | 31.08% | 0.16% |
| 1Y Return | 14.90% | -10.27% |
| 3Y Return (Ann) | 14.23% | -9.48% |
| 5Y Return (Ann) | 23.24% | 0.94% |
| 10Y Return (Ann) | 26.25% | 3.10% |
| Sharpe Ratio | 0.50 | -0.57 |
| Daily Std Dev | 37.63% | 21.35% |
| Max Drawdown | -75.69% | -65.03% |
| Current Drawdown | 0.00% | -28.16% |
Fundamentals
| LMAT | ZBH | |
|---|---|---|
| Market Cap | $1.47B | $24.52B |
| EPS | $1.34 | $4.88 |
| PE Ratio | 48.85 | 24.46 |
| PEG Ratio | 2.77 | 4.69 |
| Revenue (TTM) | $193.48M | $7.39B |
| Gross Profit (TTM) | $104.90M | $4.92B |
| EBITDA (TTM) | $46.71M | $2.45B |
Correlation
The correlation between LMAT and ZBH is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
LMAT vs. ZBH - Performance Comparison
In the year-to-date period, LMAT achieves a 31.08% return, which is significantly higher than ZBH's 0.16% return. Over the past 10 years, LMAT has outperformed ZBH with an annualized return of 26.25%, while ZBH has yielded a comparatively lower 3.10% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LMAT vs. ZBH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for LeMaitre Vascular, Inc. (LMAT) and Zimmer Biomet Holdings, Inc. (ZBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LMAT vs. ZBH - Dividend Comparison
LMAT's dividend yield for the trailing twelve months is around 0.78%, less than ZBH's 0.79% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LMAT LeMaitre Vascular, Inc. | 0.78% | 0.99% | 1.09% | 0.88% | 0.94% | 0.95% | 1.18% | 0.69% | 0.71% | 0.93% | 1.83% | 1.50% |
ZBH Zimmer Biomet Holdings, Inc. | 0.79% | 0.79% | 0.75% | 0.76% | 0.62% | 0.64% | 0.93% | 0.80% | 0.93% | 0.86% | 0.78% | 0.86% |
Drawdowns
LMAT vs. ZBH - Drawdown Comparison
The maximum LMAT drawdown since its inception was -75.69%, which is greater than ZBH's maximum drawdown of -65.03%. Use the drawdown chart below to compare losses from any high point for LMAT and ZBH. For additional features, visit the drawdowns tool.
Volatility
LMAT vs. ZBH - Volatility Comparison
LeMaitre Vascular, Inc. (LMAT) has a higher volatility of 13.00% compared to Zimmer Biomet Holdings, Inc. (ZBH) at 5.95%. This indicates that LMAT's price experiences larger fluctuations and is considered to be riskier than ZBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
LMAT vs. ZBH - Financials Comparison
This section allows you to compare key financial metrics between LeMaitre Vascular, Inc. and Zimmer Biomet Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities